semaglutide and prostate cancer Targeting obesity, metabolic syndrome, cancer: GLP-1 agonists as emerging therapeutic agents | Discover Oncology ESMO 2024: Targeting Epigenetic Pathways
Pay in 4 interest-free payments of $6.16 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20





























